|
Name: stanozolol (17-alpha-methyl-17-beta-hydroxy-5-alpha-androst-2-eno[3,2-c]-pyrazole)
Type: Androgenic steroid
AKA: N/A
![stanozolol (17-alpha-methyl-17-beta-hydroxy-5-alpha-androst-2-eno[3,2-c]-pyrazole) image](https://grammasearch.com/dev/v2/aiimages/stanozolol_%2817-alpha-methyl-17-beta-hydroxy-5-alpha-androst-2-eno%5B3%2C2-c%5D-pyrazole%29.png)
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
![stanozolol (17-alpha-methyl-17-beta-hydroxy-5-alpha-androst-2-eno[3,2-c]-pyrazole) image](/dev/v2/pages/pubchem_images/10418.png)
|
|
IV. History
Stanozolol, an anabolic steroid, was first synthesized in 1962 by chemist Daniel Duchin. It was developed to enhance muscle growth and improve athletic performance. Initially marketed under the brand name Winstrol, stanozolol gained popularity among bodybuilders and athletes for its performance-enhancing properties. It was used both in veterinary medicine and human medicine to treat various conditions such as anemia and weight loss. However, its potential for abuse in sports led to its inclusion on the World Anti-Doping Agency's list of banned substances. Over time, the regulatory focus has shifted to controlling its misuse while acknowledging its legitimate medical applications.
|
|
V. Legal Information
Stanozolol is an anabolic steroid used to enhance athletic performance. It is regulated under steroid laws in the U.S. and faces international controls to prevent misuse in sports and bodybuilding. [Source: UNODC].
US Federal Schedule - III
Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Some examples of Schedule III drugs are: products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Stanozolol is an anabolic steroid used for muscle growth. It acts as an upper, enhancing muscle mass and strength. Short-term use can improve physical performance, but long-term use may lead to hormonal imbalances, cardiovascular issues, and liver damage. Overdose risks include severe health complications. Safe use involves careful dosing and monitoring. Recent research examines its effectiveness and associated health risks.  |
|
VII. Psychological Effects
Stanozolol, an anabolic steroid, affects mood and aggression through androgen receptor interactions. Immediate effects include increased energy and mood enhancement. Long-term use may result in mood swings, aggression, and cognitive impairments. Research emphasizes its impact on neurotransmitter systems and psychological risks associated with long-term steroid use.
 |
|
VIII. Culture
Stanozolol is an anabolic steroid used in bodybuilding and athletics, gaining attention in the late 20th century. Its cultural significance includes its role in performance enhancement and related controversies. Proponents highlight its muscle-building effects, while opponents warn of health risks and ethical concerns in sports. Its use is primarily for performance enhancement.
 |